A Bidirectional Survivin Promoter Enhances IL-2, GM-CSF, and Apoptin Co-expression for Breast Cancer Gene Therapy.

Barzegari O, Ghadimi F, Shamsabadi FT, Golalipour M, Shahbazi M

Open source

DOI
10.1111/aji.70226
Published
2026 May
Container
American journal of reproductive immunology (New York, N.Y. : 1989)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/aji.70226,
  title = {A Bidirectional Survivin Promoter Enhances IL-2, GM-CSF, and Apoptin Co-expression for Breast Cancer Gene Therapy.},
  author = {Barzegari O and Ghadimi F and Shamsabadi FT and Golalipour M and Shahbazi M},
  year = {2026},
  journal = {American journal of reproductive immunology (New York, N.Y. : 1989)},
  doi = {10.1111/aji.70226},
  url = {https://doi.org/10.1111/aji.70226}
}

RIS

TY  - JOUR
TI  - A Bidirectional Survivin Promoter Enhances IL-2, GM-CSF, and Apoptin Co-expression for Breast Cancer Gene Therapy.
AU  - Barzegari O
AU  - Ghadimi F
AU  - Shamsabadi FT
AU  - Golalipour M
AU  - Shahbazi M
PY  - 2026
JO  - American journal of reproductive immunology (New York, N.Y. : 1989)
DO  - 10.1111/aji.70226
UR  - https://doi.org/10.1111/aji.70226
ER  - 

APA

O, B., F, G., FT, S., M, G., & M, S. (2026). A Bidirectional Survivin Promoter Enhances IL-2, GM-CSF, and Apoptin Co-expression for Breast Cancer Gene Therapy.. American journal of reproductive immunology (New York, N.Y. : 1989). https://doi.org/10.1111/aji.70226

Source records